NCT04651998

Brief Summary

Cerebral hemodynamic compromise from internal carotid artery stenosis may be a cause of vascular cognitive impairment that is amenable to treatment by revascularization. The effect of carotid artery stent on evoked cerebral blood oxygenation and neurocognitive functioning will be evaluated by functional near-infrared spectroscopy. Carotid artery stent could benefit cerebral blood oxygenation after stent and improving neurocognitive functioning after 6 months.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
74

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 24, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 3, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

May 1, 2021

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

May 29, 2024

Status Verified

June 1, 2023

Enrollment Period

3.4 years

First QC Date

November 24, 2020

Last Update Submit

May 27, 2024

Conditions

Keywords

carotid artery stent, functional near-infrared spectroscopy, vascular cognitive impairment,

Outcome Measures

Primary Outcomes (1)

  • Change of cognitive function score

    Mini-mental State Examination (0-30 points), the higher the score, the better the cognitive function

    MMSE score at baseline, 6 months after revascularization. Change of the score is calculated.

Secondary Outcomes (3)

  • Parameter of evoked cerebral blood oxygenation

    Evoked cerebral blood oxygenation evaluated after stent immediately, 6 months later, compared with that at baseline.

  • Parameter of evoked cerebral blood oxygenation

    Evoked cerebral blood oxygenation evaluated after stent immediately, 6 months later, compared with that at baseline.

  • Parameter of evoked cerebral blood oxygenation

    Evoked cerebral blood oxygenation evaluated after stent immediately, 6 months later, compared with that at baseline.

Interventions

MMSE and MoCA are used for cognitive test before carotid artery stent implant and 6 months later. Cerebral blood oxygenation is evaluated by functional near-infrared spectroscopy under the mental task before and after revascularization within one week, 6 months later respectively.

Eligibility Criteria

Age35 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with high grade carotid artery stenosis treated with carotid artery stent from 5 hospitals.

You may qualify if:

  • years old
  • Severe carotid stenosis (MRA or CTA confirmed stenosis rate of 70% - 99%, NASCET standard)
  • Asymptomatic or mild stroke (NIHSS ≤ 3) or TIA
  • Agree to participate in the clinical trial and sign the informed consent

You may not qualify if:

  • Severe stenosis or occlusion of vertebrobasilar artery and other intracranial arteries (70% - 99%)
  • Left ventricular ejection fraction \< 50% or heart failure
  • Other types of dementia have been diagnosed
  • Severe depression, mental illness, epilepsy
  • Not cooperating with cognitive task evaluation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai 6th People's Hospital

Shanghai, 200023, China

RECRUITING

MeSH Terms

Conditions

Carotid Stenosis

Condition Hierarchy (Ancestors)

Carotid Artery DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Yueqi Zhu, PhD

    Shanghai Jiao Tong University Affiliated Sixth People's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jiangshan Deng, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 24, 2020

First Posted

December 3, 2020

Study Start

May 1, 2021

Primary Completion

September 30, 2024

Study Completion

December 30, 2024

Last Updated

May 29, 2024

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations